Trial Profile
Comparison Between Amlodipine and Aliskiren in Diabetic Hypertensive Patient With Blood Pressure Not Controlled by Losartan: Effects on Endothelial Function and Renin Concentration and Activity.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary) ; Amlodipine (Primary)
- Indications Hypertension
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms CAALIDH
- 05 Mar 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 09 Aug 2011 New trial record